GO:2000726 negative regulation of cardiac muscle cell differentiation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000726 describes any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation.
• MicroRNAs are major negative regulators of cardiomyocyte differentiation, acting as key drivers of both inducers and repressors of this process.
• RhoA signaling has been shown to regulate cardiomyocyte differentiation, providing a GTPase-dependent layer of negative control.
• Cardiac regenerative capacity is limited in adult mammals, and understanding negative regulation of cardiomyocyte differentiation is central to regenerative strategies.
• Klf4 and Oct4, classic stem cell pluripotency genes, regulate complex smooth muscle cell phenotypic changes that are critical in late-stage atherosclerotic lesion pathogenesis.
• Protein lactylation is linked to cardiac metabolic reprogramming in neonatal mouse hearts, connecting metabolism to cardiac cell state.
Description
Cardiac muscle cell differentiation is the process by which progenitor cells acquire the specialized structure and function of cardiomyocytes. GO:2000726, negative regulation of cardiac muscle cell differentiation, refers to any process that stops, prevents or reduces the frequency, rate or extent of this differentiation. This regulatory term is essential for understanding how the heart controls the balance between progenitor maintenance and terminal differentiation, a balance that is critical for both normal development and regenerative medicine. MicroRNAs have emerged as key drivers of inducers and repressors of cardiomyocyte differentiation, highlighting the complexity of this negative regulatory layer. In addition, RhoA signaling has been demonstrated to regulate cardiomyocyte differentiation, showing that small GTPase pathways can modulate this process. Understanding GO:2000726 is therefore important for researchers aiming to manipulate cardiac cell fate in vitro and in vivo.
negative regulation of cardiac muscle cell differentiation At A Glance
| GO ID | GO:2000726 |
|---|---|
| GO term | negative regulation of cardiac muscle cell differentiation |
| Ontology | biological_process |
| Synonym | negative regulation of cardiomyocyte differentiation; negative regulation of heart muscle cell differentiation |
| Major function | Stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation |
| Related processes | Cardiomyocyte differentiation, cardiac regeneration, microRNA regulation, RhoA signaling |
| Key regulators | MicroRNAs, RhoA, Klf4, Oct4, metabolic and lactylation pathways |
| Disease relevance | Cardiovascular disease, atherosclerosis, neuromuscular disorders, regenerative failure |
What Is GO:2000726?
In simple terms, GO:2000726 covers all biological processes that put the brakes on cardiac muscle cell differentiation. According to the QuickGO definition, it is any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation. This includes molecular mechanisms such as microRNA-mediated repression, signaling pathway inhibition, and transcriptional control that keep progenitor cells from becoming mature cardiomyocytes. The term is synonymous with negative regulation of cardiomyocyte differentiation and negative regulation of heart muscle cell differentiation.
Why Is negative regulation of cardiac muscle cell differentiation Important in Cell Biology?
GO:2000726 is important because the heart has very limited regenerative capacity, and the negative regulation of cardiomyocyte differentiation directly influences whether cardiac progenitors remain proliferative or become terminally differentiated. Dysregulation of this process can contribute to developmental defects, impaired cardiac repair, and diseases such as atherosclerosis where smooth muscle cell phenotypic changes are critical. MicroRNAs that negatively regulate cardiomyocyte differentiation are considered key drivers of both inducers and repressors of this process, making them attractive targets for therapeutic intervention. Moreover, signaling pathways such as RhoA provide druggable nodes for controlling cardiomyocyte differentiation. Therefore, studying GO:2000726 helps researchers understand fundamental cardiac biology and develop strategies for cardiac regeneration.
• Controls the balance between cardiac progenitor proliferation and terminal differentiation.
• MicroRNAs act as major negative regulators of cardiomyocyte differentiation.
• RhoA signaling modulates cardiomyocyte differentiation, offering a potential therapeutic target.
• Klf4 and Oct4 regulate smooth muscle cell phenotypic changes relevant to atherosclerosis.
• Protein lactylation is linked to cardiac metabolic reprogramming in neonatal hearts.
• Cardiac regenerative capacity is limited, making negative regulation a barrier to regeneration.
• Dysregulation may contribute to neuromuscular disorders through satellite cell dysfunction.
• Understanding this term aids in designing cell-based therapies for heart disease.
• It provides a framework for studying gene regulatory networks in cardiac development.
• It connects metabolic state to cardiac cell fate decisions.
What Happens During negative regulation of cardiac muscle cell differentiation?
MicroRNA-mediated repression
In simple terms: Small RNA molecules can block the production of proteins that drive heart muscle cell differentiation.
MicroRNAs are key negative regulators of cardiomyocyte differentiation, acting as drivers of both inducers and repressors of this process. They typically bind to complementary sequences in target mRNAs and inhibit translation or promote degradation, thereby reducing the levels of proteins required for differentiation. This layer of post-transcriptional control allows rapid and reversible modulation of cardiac cell fate.
RhoA signaling pathway
In simple terms: A molecular switch called RhoA can send signals that keep heart muscle cells from differentiating.
RhoA regulation of cardiomyocyte differentiation has been demonstrated, indicating that this small GTPase can negatively influence the differentiation process. RhoA acts through downstream effectors to modulate cytoskeletal dynamics and gene expression, thereby affecting the ability of cardiac progenitors to undergo differentiation.
Pluripotency factor involvement
In simple terms: Stem cell genes like Klf4 and Oct4 can influence how smooth muscle cells change their identity.
Klf4 and Oct4, classic stem cell pluripotency genes, regulate complex smooth muscle cell phenotypic changes that are critical in late-stage atherosclerotic lesion pathogenesis. Although this study focuses on smooth muscle cells, it highlights how pluripotency-associated factors can modulate differentiation programs in cardiovascular contexts.
Metabolic and lactylation control
In simple terms: Chemical modifications on proteins caused by metabolism can affect how heart cells mature.
Protein lactylation is linked to cardiac metabolic reprogramming in neonatal mouse hearts, connecting metabolic state to cardiac cell differentiation. This suggests that metabolic intermediates can act as signals that influence the negative regulation of cardiac muscle cell differentiation.
Regenerative capacity limitation
In simple terms: The heart's inability to regenerate is partly due to brakes on heart muscle cell differentiation.
Cardiac regenerative capacity is considered an evolutionary afterthought, and the negative regulation of cardiomyocyte differentiation contributes to this limited regenerative potential. Understanding these brakes is essential for developing strategies to enhance cardiac repair.
Key Genes Involved in GO:2000726 negative regulation of cardiac muscle cell differentiation
The following genes and proteins have been implicated in the negative regulation of cardiac muscle cell differentiation or related cardiovascular differentiation processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MIRNAs (e.g., miR-1, miR-133) | Post-transcriptional repression of differentiation-promoting genes | Key drivers of inducers and repressors of cardiomyocyte differentiation |
| RHOA | Small GTPase signaling that modulates differentiation | Regulates cardiomyocyte differentiation |
| KLF4 | Pluripotency factor regulating smooth muscle cell phenotypic changes | Critical in late-stage atherosclerotic lesion pathogenesis |
| OCT4 (POU5F1) | Pluripotency factor regulating smooth muscle cell phenotypic changes | Critical in late-stage atherosclerotic lesion pathogenesis |
| Lactylation-related proteins | Metabolic modification of proteins | Linked to cardiac metabolic reprogramming in neonatal hearts |
| Satellite cell-related genes | Muscle stem cell function | Involved in neuromuscular disorders |
| Cardiac progenitor markers | Maintain progenitor state | Balance between proliferation and differentiation |
| Cell cycle regulators | Control proliferation vs. differentiation | Defining molecular underpinnings of cardiomyocyte proliferation |
| Transcription factors (e.g., GATA4, MEF2C) | Drive cardiomyocyte differentiation | Targets of negative regulation |
| Signaling pathway components (e.g., Wnt, Notch) | Modulate differentiation decisions | Potential nodes for intervention |
| Metabolic enzymes | Regulate metabolic reprogramming | Connected to lactylation and cardiac maturation |
| MicroRNA processing machinery | Generate mature microRNAs | Essential for microRNA-mediated repression |
| RhoA effectors (e.g., ROCK) | Cytoskeletal dynamics | Downstream of RhoA in differentiation control |
| Pluripotency network genes | Maintain stemness | Influence smooth muscle cell phenotype |
| Neuromuscular junction genes | Muscle function | Relevant to satellite cell-opathies |
| Cardiac regeneration factors | Promote regeneration | Counteracted by negative regulation |
| Proliferation markers (e.g., Ki67) | Cell cycle entry | Readout of differentiation state |
How Is negative regulation of cardiac muscle cell differentiation Regulated?
The negative regulation of cardiac muscle cell differentiation is itself controlled by multiple layers of regulation. MicroRNAs provide a post-transcriptional layer that can rapidly adjust the levels of differentiation-promoting proteins. RhoA signaling adds a GTPase-dependent control mechanism that influences cytoskeletal dynamics and gene expression. Pluripotency factors such as Klf4 and Oct4 can modulate smooth muscle cell phenotypic changes, indicating that stemness networks can impinge on cardiovascular differentiation programs. Metabolic state, including protein lactylation, is linked to cardiac metabolic reprogramming and can influence cardiac cell fate. Finally, the limited regenerative capacity of the heart reflects an evolutionary balance where negative regulation predominates.
negative regulation of cardiac muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KLF4 | Atherosclerosis, smooth muscle cell phenotypic changes | Knockout mouse, smooth muscle cell-specific KO |
| OCT4 (POU5F1) | Atherosclerosis, smooth muscle cell phenotypic changes | Knockout mouse, smooth muscle cell-specific KO |
| RHOA | Cardiomyocyte differentiation, cardiac development | Cardiac-specific RhoA knockout or overexpression |
| MicroRNAs (e.g., miR-1, miR-133) | Cardiac differentiation, regeneration | MicroRNA sponge or knockout models |
| Lactylation-related genes | Cardiac metabolic reprogramming | Neonatal mouse heart models |
Cardiovascular disease and atherosclerosis
Klf4 and Oct4 regulate complex smooth muscle cell phenotypic changes that are critical in late-stage atherosclerotic lesion pathogenesis. Dysregulation of negative regulation of cardiac muscle cell differentiation may contribute to vascular remodeling and plaque instability. Understanding these mechanisms could reveal new therapeutic targets for atherosclerosis.
Heart failure and regenerative failure
The heart has limited regenerative capacity, and the negative regulation of cardiomyocyte differentiation acts as a barrier to endogenous repair. After injury, cardiomyocytes are lost and cannot be efficiently replaced. Modulating GO:2000726 could potentially enhance cardiac regeneration.
Neuromuscular disorders
Muscle satellite cell dysfunction is involved in neuromuscular disorders, and similar mechanisms may affect cardiac muscle progenitors. Although the cited study focuses on skeletal muscle, it highlights how stem cell dysfunction can contribute to muscle-related diseases.
From negative regulation of cardiac muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance cardiomyocyte differentiation? | Knockout (KO) via CRISPR-Cas9 in cardiac progenitor cells |
| Does a specific point mutation in a signaling gene alter differentiation? | Point mutation knock-in using CRISPR |
| Does tagging a protein affect its function in differentiation? | Tagged knock-in (e.g., GFP) |
| Does overexpression of a microRNA repress differentiation? | Overexpression via lentiviral transduction |
| Does metabolic reprogramming influence differentiation? | Metabolic perturbation in neonatal mouse hearts |
| Does RhoA signaling modulate differentiation? | RhoA knockout or pharmacological inhibition |
How to Study the negative regulation of cardiac muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify microRNA targets and differentiation markers |
| Proteomics | Protein abundance and modifications | Detect lactylation and signaling changes |
| Immunofluorescence | Protein localization and cell morphology | Assess cardiomyocyte differentiation |
| EdU incorporation | DNA synthesis / proliferation | Measure progenitor proliferation |
| Lineage tracing | Cell fate mapping | Track cardiac progenitor differentiation |
| Western blot | Protein expression levels | Validate knockout or overexpression |
| qRT-PCR | mRNA levels | Quantify microRNA and target genes |
| CRISPR screening | Gene function at scale | Identify novel regulators of differentiation |
Transcriptomic analysis
RNA sequencing can identify changes in gene expression associated with negative regulation of cardiac muscle cell differentiation. MicroRNAs and their targets can be profiled to understand post-transcriptional control.
Proteomic and lactylation profiling
Proteomics and lactylation-specific antibodies can reveal protein modifications linked to cardiac metabolic reprogramming. These methods help connect metabolic state to differentiation.
Imaging and lineage tracing
Fluorescent reporters and lineage tracing in animal models allow visualization of cardiomyocyte differentiation in vivo. This is useful for studying RhoA signaling and regenerative capacity.
Functional assays
Proliferation and differentiation assays, such as EdU incorporation and cardiac troponin staining, measure the effects of genetic perturbations.
How CRISPR Can Be Used to Study GO:2000726 negative regulation of cardiac muscle cell differentiation
Knockout
CRISPR-Cas9 knockout can be used to delete candidate genes such as RhoA or microRNA clusters to test whether they are required for the negative regulation of cardiac muscle cell differentiation. Knockout models help establish causality.
Point Mutation
Point mutations can be introduced into signaling genes to mimic disease-associated variants or to disable specific phosphorylation sites. This is useful for studying RhoA effectors and other regulatory nodes.
Knock-in
Knock-in of reporter tags or conditional alleles allows precise tracking of proteins involved in differentiation. For example, tagging lactylation-related proteins can reveal their dynamics.
Overexpression
Overexpression of microRNAs or pluripotency factors such as Klf4 and Oct4 can be achieved via CRISPR activation or lentiviral delivery to test their ability to repress differentiation.
How EDITGENE Supports negative regulation of cardiac muscle cell differentiation Research
Researchers studying negative regulation of cardiac muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in controlling cardiomyocyte fate. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cardiac muscle cell differentiation research.
Frequently Asked Questions About negative regulation of cardiac muscle cell differentiation
What is GO:2000726?
GO:2000726 is the Gene Ontology term for negative regulation of cardiac muscle cell differentiation, defined as any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation.
What genes are involved in negative regulation of cardiac muscle cell differentiation?
Key genes include microRNAs, RHOA, KLF4, OCT4, and metabolic genes related to lactylation.
How do microRNAs regulate cardiomyocyte differentiation?
MicroRNAs act as key drivers of inducers and repressors of cardiomyocyte differentiation by post-transcriptionally repressing target mRNAs.
What is the role of RhoA in cardiomyocyte differentiation?
RhoA signaling regulates cardiomyocyte differentiation, acting as a negative regulator through downstream effectors.
Why is cardiac regeneration limited?
Cardiac regenerative capacity is considered an evolutionary afterthought, and negative regulation of cardiomyocyte differentiation contributes to this limitation.
How can I study negative regulation of cardiac muscle cell differentiation?
Researchers use CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and imaging to study this process.
What diseases are associated with dysregulated cardiac muscle cell differentiation?
Atherosclerosis, heart failure, and neuromuscular disorders have been linked to dysregulation of cardiac differentiation processes.
What is the role of Klf4 and Oct4 in cardiovascular disease?
Klf4 and Oct4 regulate complex smooth muscle cell phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis.
How does protein lactylation affect cardiac cells?
Protein lactylation is linked to cardiac metabolic reprogramming in neonatal mouse hearts, influencing cardiac cell state.
What CRISPR services are available for cardiac differentiation research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services for cardiac differentiation research.
Conclusion
GO:2000726, negative regulation of cardiac muscle cell differentiation, is a critical biological process that controls the balance between cardiac progenitor proliferation and terminal differentiation. MicroRNAs, RhoA signaling, pluripotency factors, and metabolic modifications all contribute to this regulation. Dysregulation of this process is linked to cardiovascular diseases such as atherosclerosis and heart failure, as well as limited cardiac regeneration. Understanding the molecular mechanisms and key genes involved provides a foundation for developing therapeutic strategies to enhance cardiac repair. EDITGENE's CRISPR services can help researchers dissect these pathways and identify novel targets.
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 3. Alencar GF et al.. 2020. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.. Circulation 142(21):2045-2059 PMID: 32674599
- 4. Zhang T et al.. 2024. The characterization of protein lactylation in relation to cardiac metabolic reprogramming in neonatal mouse hearts.. J Genet Genomics 51(7):735-748 PMID: 38479452
- 5. Nguyen PD et al.. 2021. Cardiac regenerative capacity: an evolutionary afterthought?. Cell Mol Life Sci 78(12):5107-5122 PMID: 33950316
- 6. Cianflone E et al.. 2022. The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation.. Clin Sci (Lond) 136(16):1179-1203 PMID: 35979890
- 7. Kaarbø M et al.. 2013. RhoA regulation of cardiomyocyte differentiation.. ScientificWorldJournal 2013:491546 PMID: 23935420
- 8. Mahiny-Shahmohammady D et al.. 2022. Defining the molecular underpinnings controlling cardiomyocyte proliferation.. Clin Sci (Lond) 136(12):911-934 PMID: 35723259
